Supported
Individual vs. Structural
IndividualStructural

Regulatory capture structurally undermines market competition

Regulatory agencies tasked with policing industries are systematically captured by the industries they regulate, turning rules designed to protect consumers and workers into barriers that protect incumbents and suppress competition.

Agencies from the FCC to the SEC consistently adopt the policy preferences of regulated industries, and the revolving door, notice-and-comment asymmetry, and post-Chevron deference each amplify this dynamic.

Who benefits from the prevailing framing
Telecom incumbents (AT&T, Comcast, Verizon), large pharmaceutical manufacturers, major financial institutions (Goldman Sachs, JPMorgan, BlackRock), investor-owned electric utilities, and the trade associations that represent them.
Comparator cases
GermanyNetherlandsSwedenDenmarkUK

The claim

Regulatory agencies in the United States — the FCC, SEC, FDA, FERC, CFPB, FTC, and others — were created to discipline markets in the public interest: to prevent monopoly, protect consumers and workers, ensure financial stability, and internalize externalities. The structural claim advanced here is that these agencies have been systematically captured by the industries they nominally police. Under capture, regulations nominally designed to discipline markets are instead designed or administered to entrench incumbents, raise barriers to entry for competitors, and suppress the very competition they were meant to protect. The result is not deregulation but privatized regulation: rules that serve the industry rather than the public, enforced or waived at the industry’s discretion. Proponents of this view hold that capture is not an aberration caused by corrupt individuals but a structural feature of the relationship between regulated industries and the agencies that depend on them for information, personnel, and — in fee-funded agencies — operating budgets.

The mechanism

George Stigler’s 1971 paper “The Theory of Economic Regulation” in the Bell Journal of Economics remains the foundational statement of the capture thesis. Stigler argued that regulation is a product, supplied by government and demanded by industry, and that well-organized industries with concentrated interests will systematically outbid diffuse publics in the political market for regulatory outputs. The mechanism has three reinforcing channels.

The first is the revolving door. Regulatory agencies rely on industry expertise to staff technical positions; former regulators command a large salary premium in the private sector. The result is a career-path incentive structure in which regulators anticipate future employment in the industry they oversee, and therefore avoid decisions that would damage those future employers. This is not a theory about bribery — the mechanism operates through legitimate career planning. Gary Reback’s work on the FTC and Sam Peltzman’s 1976 extension of Stigler formalized why this dynamic is self-reinforcing: agencies that are aggressive early in their careers may simply not be hired by industry later, creating a selection effect that staffs the revolving door with accommodating regulators.

The second channel is information asymmetry. Regulated industries possess technical knowledge that regulators need to do their jobs — pharmaceutical firms know the safety data, financial firms know the trading mechanics, utilities know the grid topology. Agencies that cannot independently verify industry claims become structurally dependent on those claims, and industries have strong incentives to selectively disclose information that supports favorable regulation. This mechanism is particularly powerful in the FDA’s Prescription Drug User Fee Act (PDUFA) context, where the same firms funding the review also supply the clinical trial data that is being reviewed.

The third channel is the notice-and-comment asymmetry documented by Yackee and Yackee (2006) in the American Journal of Political Science and extended by Haeder and Yackee (2015). Public notice-and-comment rulemaking — theoretically a democratic input into regulatory design — produces comment records dominated by industry participants. Industries can afford specialized regulatory counsel, economics consultants, and sustained engagement across multi-year rulemakings; consumer organizations, labor unions, and public interest groups cannot. Susan Yackee’s research found that the more industry-aligned the comment record, the more the final rule deviates from the proposed rule in the industry’s direction — a clean empirical result linking comment-record composition to regulatory outcomes.

The evidence

The revolving door: quantitative record

The Project on Government Oversight’s 2011 analysis of SEC revolving-door disclosures found that 419 former SEC employees filed 1,949 disclosures of working for or representing entities regulated by the SEC between 2001 and 2010, with 58% of departing senior officials moving to regulated entities within two years of departure. A 2020 follow-up found similar patterns persisted post-Dodd-Frank. The revolving door is not unique to the SEC: a University of Maryland study by Blanes i Vidal, Draca, and Fons-Rosen (2012, American Economic Review) found that Congressional staffers who moved to lobbying firms saw their clients’ lobbying revenues fall sharply when their former employer left office, quantifying the connection between agency access and the value of regulatory relationships. For financial regulators specifically, Lucian Bebchuk and Holger Spamann (2010) documented that the composition of Federal Reserve and Treasury staffing in the years preceding the 2008 financial crisis tracked industry preferences on leverage limits, derivatives regulation, and capital requirements to a degree inconsistent with independent technical judgment.

FCC and telecom consolidation

The Federal Communications Commission’s history since the 1996 Telecommunications Act is among the clearest documented cases of capture producing consumer harm. The 1996 Act was designed to promote competition in local telephone markets; instead, the FCC oversaw a wave of mergers that reconcentrated the market and used its authority over spectrum allocation, interconnection rules, and broadband classification to benefit the dominant carriers. The 2017 repeal of net neutrality rules by FCC Chairman Ajit Pai — who had previously served as associate general counsel at Verizon — followed a comment process in which the agency’s own analysis later acknowledged receiving millions of fake public comments, with authentic public opposition to repeal running at roughly 99% of real comments while the agency proceeded with repeal regardless. The outcome is measurable: the United States has among the highest broadband prices and lowest coverage-per-capita ratios among OECD peer nations. The Netherlands and Germany, whose telecoms regulators (ACM and Bundesnetzagentur) operate with explicit structural independence mandates and open-access requirements, have average broadband prices 50–70% lower than comparable US tiers and near-universal gigabit availability.

SEC and Wall Street post-2008

The 2008 financial crisis and subsequent Dodd-Frank rulemaking provide a high-information natural experiment in regulatory capture dynamics. Dodd-Frank authorized more than 400 new rules across multiple agencies; by 2015, fewer than two-thirds had been finalized, with the most consequential rules — the Volcker Rule on proprietary trading, derivatives clearing mandates, systemically important financial institution (SIFI) designations — either watered down in final form or subject to extended litigation by industry. Dennis Kelleher of Better Markets documented in congressional testimony that the five largest US financial institutions — JPMorgan, Goldman Sachs, Bank of America, Citigroup, and Wells Fargo — spent more than $1 billion on lobbying and political contributions in the five-year period following Dodd-Frank’s passage, with measurable effects on the final content of derivatives rules relative to the CFTC’s proposed versions. Raghuram Rajan’s 2010 book Fault Lines argued that the financial sector’s ability to shape its own regulation was not incidental to the 2008 crisis but constitutive of it — that the pre-crisis regulatory framework was not a failure of enforcement but a deliberate regulatory architecture shaped by industry preferences over two decades.

FERC and energy utilities

The Federal Energy Regulatory Commission’s treatment of natural gas pipeline certification applications illustrates capture in an agency that attracts less public attention than the SEC or FCC. Between 2000 and 2018, FERC approved 98.6% of all certificate applications, with outright denial being effectively unknown. The agency’s certificate policy, last substantively revised in 1999, required only that applicants demonstrate market need — a test that could be satisfied by contracts with affiliated subsidiaries, creating a circularity that industry participants exploited systematically. FERC’s majority was staffed throughout this period by former utility company executives and industry attorneys, cycling through the commission via the revolving door documented by the Energy Policy Advocates watchdog group. When FERC undertook a policy review in 2018 under Chairman Kevin McIntyre, the review was quietly shelved after McIntyre’s death; the 2021 Biden-era draft policy update was subsequently reversed under the following commission composition. The European comparison is stark: Germany’s Bundesnetzagentur, which regulates both energy networks and telecoms, operates under an explicit independence mandate in the Energy Industry Act (EnWG) and publishes annual assessments of competition conditions with binding market-review obligations under EU regulatory frameworks.

FDA and pharmaceutical user fees

The Prescription Drug User Fee Act (PDUFA), first enacted in 1992 and reauthorized six times, shifted a majority of FDA drug review funding from congressional appropriations to fees paid by pharmaceutical manufacturers. By fiscal year 2023, user fees funded approximately 75% of FDA’s drug review operations. This budget structure creates a structural dependence — not a corrupt one, but a systemic one — in which the agency’s operating capacity is tied to the volume and speed of approvals demanded by the industry paying for them. The Government Accountability Office’s 2022 report (GAO-22-104857) found that FDA approval times had accelerated significantly under PDUFA reauthorizations, with the GAO noting that the performance metrics negotiated under PDUFA are set in bilateral negotiations between FDA and industry rather than being set by Congress, a governance arrangement with no parallel in European Medicines Agency design. The EMA’s funding model — predominantly public with capped industry fees and transparent fee schedules — produces a different incentive structure, a point documented in comparative regulatory scholarship by Carpenter (2010) in Reputation and Power.

Notice-and-comment asymmetry

Susan Webb Yackee and Simon Yackee’s 2006 analysis in the American Journal of Political Science, examining 1,500 comment letters across 40 federal rulemakings, found that business interests submitted approximately 57% of all comments and that the ideological content of the comment record was the strongest single predictor of rule change between proposal and final issuance — stronger than the agency’s own prior stated preferences. Haeder and Yackee (2015) extended this finding to 37 major health rulemakings and found similar patterns: industry comment volume and sophistication predicted final rule content even controlling for agency statutory mandate. This is a structural argument, not an individual one: the notice-and-comment process is formally open to all, but the resource requirements for effective participation create a systematic asymmetry that routes regulatory outcomes toward industry preferences.

Who benefits

The beneficiaries of regulatory capture are incumbents in concentrated industries. In telecommunications, AT&T, Comcast, and Verizon benefit from FCC rules that have blocked municipal broadband networks (until court reversal), facilitated mergers, and maintained spectrum allocation advantages. Their trade association, CTIA — The Wireless Association, spent $23 million on lobbying in 2022 alone. In finance, the largest US banks — Goldman Sachs, JPMorgan Chase, BlackRock — benefit from SEC and Federal Reserve rules that have preserved proprietary trading structures, delayed implementation of capital requirements stronger than Basel III minimums, and limited the scope of SIFI designations. The Securities Industry and Financial Markets Association (SIFMA) is the primary lobbying vehicle. In pharmaceuticals, large branded manufacturers — Pfizer, Merck, AbbVie, Johnson & Johnson — benefit from FDA approval processes that favor complex clinical trial designs favoring well-capitalized sponsors and from post-market surveillance rules with limited enforcement. PhRMA’s annual lobbying expenditure exceeded $30 million in 2022. In energy, investor-owned utilities including NextEra, Duke Energy, and Southern Company benefit from FERC pipeline and transmission policies, with the Edison Electric Institute serving as the primary trade lobbying vehicle. The common structural feature is not that these firms are uniquely bad actors but that concentrated, well-organized industries with long time horizons and large per-firm stakes in regulatory outcomes systematically outinvest diffuse publics in the regulatory process.

The counter

The strongest counter to the regulatory capture thesis is not that capture does not occur, but that the severity of capture varies substantially across agencies and time periods, and that the mechanisms proposed are overdetermined — capture theory predicts agency behavior even in cases where independent factors provide sufficient explanation.

The FDA’s accelerated approval program, for example, can be read as either capture (industry gets faster approvals by funding the agency) or as a genuine efficiency reform (removing regulatory drag on life-saving drugs). The empirical record is genuinely mixed: Daniel Carpenter’s work on FDA reputation argues that the agency’s independence is not simply overridden by industry pressure but is maintained through reputational investment that creates long-run incentives for independence. The FDA does deny applications, does impose black-box warnings over industry objection, and has revoked accelerated approvals when post-market studies failed to confirm benefit — behaviors inconsistent with a simple capture story.

The Dodd-Frank implementation story is also more complicated than a pure capture narrative. Several of the most consequential rules — the CFPB’s qualified mortgage rule, the FDIC’s resolution authority — were implemented substantially as intended, and the 2018 rollback of bank stress-test requirements was achieved through Congress (the Economic Growth, Regulatory Relief, and Consumer Protection Act), not through agency discretion, suggesting that the political channel was legislative rather than regulatory. James Q. Wilson’s bureaucracy framework argues that agencies develop their own cultures and missions that resist capture in domains where the agency has a clear professional identity; the CFPB’s consumer complaint database, for instance, survived sustained industry opposition through three administrations.

The International Competition Network comparison is also imperfect. Germany’s Bundesnetzagentur and Sweden’s Finansinspektionen operate within EU single-market frameworks that impose external discipline on regulatory outcomes — a structural constraint that does not exist for US agencies and that may explain some of the divergence in outcomes without invoking differential capture rates. Cross-national comparisons of regulatory outcomes must be interpreted with care because differences in market structure, legal systems, and political economies confound the regulatory-capture variable.

The most careful empirical scholars — including Carpenter, Yackee, and Haeder — do not claim that capture is universal or that agencies are simply industry tools. They claim that capture is a systematic tendency with measurable effects on a specific subset of regulatory decisions, particularly in high-stakes, technically complex rulemakings where industry participation is most asymmetric. That is a defensible and supported claim, but it is narrower than the strongest version of capture theory.

References

Stigler, G. J. (1971). The theory of economic regulation. Bell Journal of Economics and Management Science, 2(1), 3–21. https://doi.org/10.2307/3003160

Peltzman, S. (1976). Toward a more general theory of regulation. Journal of Law and Economics, 19(2), 211–240. https://doi.org/10.1086/466865

Yackee, S. W., & Yackee, J. W. (2006). A bias towards business? Assessing interest group influence on the U.S. bureaucracy. Journal of Politics, 68(1), 128–139. https://doi.org/10.1111/j.1468-2508.2006.00375.x

Haeder, S. F., & Yackee, S. W. (2015). Influence and the administrative process: Lobbying the U.S. president’s Office of Management and Budget. American Political Science Review, 109(3), 507–522. https://doi.org/10.1017/S0003055415000246

Blanes i Vidal, J., Draca, M., & Fons-Rosen, C. (2012). Revolving door lobbyists. American Economic Review, 102(7), 3731–3748. https://doi.org/10.1257/aer.102.7.3731

Carpenter, D. (2010). Reputation and power: Organizational image and pharmaceutical regulation at the FDA. Princeton University Press.

Rajan, R. G. (2010). Fault lines: How hidden fractures still threaten the world economy. Princeton University Press.

Bebchuk, L. A., & Spamann, H. (2010). Regulating bankers’ pay. Georgetown Law Journal, 98(2), 247–287.

Project on Government Oversight. (2011). Dangerous liaisons: Revolving door at the SEC creates risk of regulatory capture. POGO.

Kwak, J. (2014). Cultural capture and the financial crisis. In D. Carpenter & D. A. Moss (Eds.), Preventing regulatory capture: Special interest influence and how to limit it (pp. 71–98). Cambridge University Press.